Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for
about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin …

Accurate diagnosis and staging are essential for the optimal management of cancer
patients. Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose …

The purpose of this work was to modernize recommendations for evaluation, staging, and
response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma …

Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in …

This book is the third volume of the 4th Edition of the WHO series on histological and genetic
typing of human tumours. It is an authoritative, concise reference book providing an …

Purpose Standardized response criteria are needed to interpret and compare clinical trials
and for approval of new therapeutic agents by regulatory agencies. Methods The …

Cancer cells frequently display high rates of aerobic glycolysis in comparison to their
nontransformed counterparts, although the molecular basis of this phenomenon remains …

Purpose To develop guidelines for performing and interpreting positron emission
tomography (PET) imaging for treatment assessment in patients with lymphoma both in …

The incidence of lymphoma in the United States from 2009 to 2013 was approximately 22 in
100,000 people, representing 5% of malignancies. 1 Median age at diagnosis is 63 …

[18F] Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …